Fecal lactoferrin and Clostridium spp. in stools of autistic children

Anaerobe

Volumn 17, Issue 1, 2011, Pages 43-45

  Martirosian, Gayane ^a,b   Ekiel, Alicja ^a   Aptekorz, Małgorzata ^a   Wiechuła, Barbara ^a   Kazek, Beata ^a   Jankowska Steifer, Ewa ^b   Jóźwiak, Jarosław ^b   Moskalewski, Stanisław ^b  

^a MEDICAL UNIVERSITY OF SILESIA   (Poland)

^b MEDICAL UNIVERSITY OF WARSAW   (Poland)

Author keywords

Antibiotic susceptibility; Autism; Clostridium perfringens; Lactoferrin

Indexed keywords

ANTIBIOTIC AGENT; CLINDAMYCIN; CLOSTRIDIUM DIFFICILE TOXIN A; CLOSTRIDIUM DIFFICILE TOXIN B; ENTEROTOXIN; ERYTHROMYCIN; IMIPENEM; LACTOFERRIN; METRONIDAZOLE; MOXIFLOXACIN; PENICILLIN G; PIPERACILLIN PLUS TAZOBACTAM; VANCOMYCIN;

ADOLESCENT; ADULT; ANTIBIOTIC SENSITIVITY; ARTICLE; AUTISM; BACTERIAL STRAIN; BACTERIUM CULTURE; BACTERIUM ISOLATION; CHILD; CLINICAL ARTICLE; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM PERFRINGENS; CONTROLLED STUDY; FECES ANALYSIS; FECES MICROFLORA; FEMALE; HUMAN; MALE; MINIMUM INHIBITORY CONCENTRATION; NEUROLOGIC DISEASE; NONHUMAN; PRIORITY JOURNAL; SEX RATIO;

ADOLESCENT; ANTI-BACTERIAL AGENTS; AUTISTIC DISORDER; BACTERIAL TOXINS; CHILD; CHILD, PRESCHOOL; CLOSTRIDIUM; FECES; FEMALE; HUMANS; LACTOFERRIN; MALE; MICROBIAL SENSITIVITY TESTS;

CLOSTRIDIUM; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM PERFRINGENS;

EID: 79951508080     PISSN: 10759964     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.anaerobe.2010.12.003     Document Type: Article

References (22)

1. Kanner L. Autistic disturbances of effective contact. Nerv Child 1943, 2:217-250.
2. Frith U. Mind blindness and the brain in autism. Neuron 2001, 32:969-979.
3. Croen L.A., Grether J.K., Selvin S. The changing prevalence of autism in California. J Autism Dev Disord 2002, 32:207-215.
4. Yeargin-Allsopp M., Rice C., Karapurkar T., Doernberg N., Boyle C., Murphy C. Prevalence of autism in a US metropolitan area. J Am Med Assoc 2003, 289:49-55.
5. Rosen N.J., Yoshida C.K., Croen L.A. Infection in the first 2 years of life and autism spectrum disorders. Pediatrics 2007, 119:e61-69.
6. Bolte E.R. Autism and Clostridium tetani. Med Hypotheses 1998, 51:133-144.
7. Parracho H.M., Bingham M.O., Gibson G.R., McCartney A.L. Differences between the gut microflora of children with autistic spectrum disorders and that of healthy children. J Med Microbiol 2005, 54:987-991.
8. Walker T.R., Land M.L., Kastashov A., Saslowsky T.M., Lyerly D.M., Boone J.H., et al. Fecal lactoferrin is a sensitive and specific maker of disease activity in children and young adults with inflammatory bowel disease. J Pediatr Gastroenterol Nutr 2007, 44:414-422.
9. Lamb C.A., Mohiuddin M.K., Gicquel J., Neely D., Bergin F.G., Hanson J.M., et al. Faecal calprotectin or lactoferrin can identify postoperative recurrence in Crohn's disease. Br J Surg 2009, 96:663-674.
10. Van Lagenberg D.R., Gearry R.B., Wong H.L., Ward M., Gibson P.R. The potential value of fecal lactoferrin as a screening test in hospitalized patients with diarrhea. Intern Med J 2009 October 22, [Epub ahead of print].
11. Sandler R.H., Finegold S.M., Bolte E.R., Buchanan C.P., Maxwell A.P., Väisänen M.L., et al. Short-term benefit from oral vancomycin treatment of regressive-onset autism. J Child Neurol 2001, 316:387.
12. World Health Organization International statistical classification of the diseases and health related problems - tenth revision 1993, World Health Organization, Genewa, Switzerland.
13. Schopler E., Lansing D.L., Reichler R.J., Marcus L.M. Psychoeducational profile 2005, Pro-Ed., Austin, TX. 3rd ed.
14. Jousimies-Somer H.R., Summanen P. Wadsworth-KTL anaerobic bacteriology manual 2002, Ed. Star Publishing Co., Belmont, CA 94002.
15. Schieven B.C., Massey V.E., Lomigan R., Hussain Z. Evaluation of susceptibility of anaerobic organisms by E tests and the reference agar dilution method. Clin Infect Dis 1995, 20(Suppl. 2):337-338.
16. Methods for antimicrobial susceptibility testing of anaerobic bacteria; Approved standard 2009, Clinical and Laboratory Standards Institute, M11-A7, vol. 27, no 2; Replaced M11-A6, vol.24, no 2. 7th ed.
17. Finegold S.M., Molitoris D., Song Y., Liu C., Vaisanen M.L., Bolte E., et al. Gastrointestinal microflora studies in late-onset autism. Clin Infect Dis 2002, 35:S6-S16.
18. Finegold S.M. Therapy and epidemiology of autism-clostridial spores as key elements. Med Hypotheses 2008, 70:508-511.
19. Song Y., Liu C., Finegold S.M. Real-time PCR quantitation of clostridia in feces of autistic children. Appl Environ Microbiol 2004, 70:6459-6465.
20. Martirosian G., Ekiel A., Aptekorz M., Kazek B., Marszał E., Jankowska-Steifer E., et al. Intestinal anaerobic bacteria and autistic mind: is there some relations? Comment to: the autistic mind: a case study. Katarzyna Markiewicz, Bruce Duncan MacQueen. Med Sci Monit 2009, 15:LE2-3.
21. Parsi M.A., Shen B., Achkar J.P., Femzi F.F., Goldblum J.R., Boone J., et al. Fecal lactoferrin for diagnosis of symptomatic patients with ileal pouch-anal anastomosis. Gastroenterology 2004, 126:1280-1286.
22. Jones J., Loffus E.V., Panaccione R., Chen L.S., Peterson S., McConnell J., et al. Relationship between disease activity and serum and fecal biomarkers in patients with Crohn's disease. Clin Gastroenterol Hepatol 2008, 11:1218-1224.